Still, there are differences between the American and the European regulations.
For example, GMPs (Good Manufacturing Practices) are still different (I heard of Japanese ones too), even if big Pharmaceutical firms produce medicines respecting either, in order to sell product everywhere.
This is also the approach towards the two different pharmacopoeias.
Maybe only small producers, unable to sell medicines in both parts of the World, work in accordance to one series of protocols only.